Mr Mrs Miss Ms Dr Other

Dr
Oliver
Chammas

Patent Attorney

London Office

Life sciences

Telephone. +44(0) 207 776 5100
Email. [email protected]

Experience

Oliver is a chartered UK and European Patent Attorney who joined the London Office in September 2020. Oliver has a PhD in Bio-Nanotechnology and a degree in Medical Biochemistry from the University of Leeds. He has a wide range of experience in prosecution, contentious matters, drafting and freedom-to-operate.

Oliver has worked in private practice in IP for four years in both London and Yorkshire with a number of clients ranging from start-ups and universities to multinational companies.

Oliver's main area of focus is nanoscale biotechnology but he has also had experience with technologies such as biologics, medical devices, medical treatments, diagnostic and analytical methods, antibody technology and second medical use inventions for a range of diseases.

Oliver has experience of patent prosecution in the UK and Europe as well as advising clients as to patent prosecution in foreign jurisdictions including the United States, Japan and China.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Medical Biochemistry - University of Leeds

MSC

Integrated PhD & MSc – Molecular Scale Engineering – University of Leeds

PHD

Thesis entitled “Atomic Force Microscopy of DNA-protein Interactions” – University of Leeds

POSTGRADUATE DIPLOMA OR CERTIFICATE

Post-Graduate Certificate in Intellectual Property - Queen Mary University of London

Related News

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

Read article

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.